Guanze Medical (02427) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend

Bulletin Express

03/18

Guanze Medical Information Industry (Holding) Co., Ltd. (stock code: 02427) has announced that its board of directors will convene on Tuesday, 31 March 2026.

The meeting agenda includes: 1. Reviewing and, if deemed appropriate, approving the audited annual results for the financial year ended 31 December 2025. 2. Considering the declaration of a final dividend for FY2025. 3. Addressing any other business matters.

Chairman Meng Xianzhen issued the notice on 18 March 2026. The board currently comprises Executive Directors Meng Xianzhen and Guo Zhenyu; Non-Executive Director Meng Cathy; and Independent Non-Executive Directors Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.

The announcement reiterates that Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited assume no responsibility for the content’s accuracy or completeness.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1118495290"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1118495290\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1118495290?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-18 18:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1118495290","market":"us","top_or_hot":-1,"title":"Guanze Medical (02427) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend","media":"Bulletin Express","content":"<p>Guanze Medical Information Industry (Holding) Co., Ltd. (stock code: 02427) has announced that its board of directors will convene on Tuesday, 31 March 2026.</p>\n<p>The meeting agenda includes:\n1. Reviewing and, if deemed appropriate, approving the audited annual results for the financial year ended 31 December 2025.\n2. Considering the declaration of a final dividend for FY2025.\n3. Addressing any other business matters.</p>\n<p>Chairman Meng Xianzhen issued the notice on 18 March 2026. The board currently comprises Executive Directors Meng Xianzhen and Guo Zhenyu; Non-Executive Director Meng Cathy; and Independent Non-Executive Directors Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.</p>\n<p>The announcement reiterates that Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited assume no responsibility for the content’s accuracy or completeness.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Guanze Medical (02427) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGuanze Medical (02427) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-18 18:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Guanze Medical Information Industry (Holding) Co., Ltd. (stock code: 02427) has announced that its board of directors will convene on Tuesday, 31 March 2026.</p>\n<p>The meeting agenda includes:\n1. Reviewing and, if deemed appropriate, approving the audited annual results for the financial year ended 31 December 2025.\n2. Considering the declaration of a final dividend for FY2025.\n3. Addressing any other business matters.</p>\n<p>Chairman Meng Xianzhen issued the notice on 18 March 2026. The board currently comprises Executive Directors Meng Xianzhen and Guo Zhenyu; Non-Executive Director Meng Cathy; and Independent Non-Executive Directors Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.</p>\n<p>The announcement reiterates that Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited assume no responsibility for the content’s accuracy or completeness.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02427","symbol_name":"GUANZE MEDICAL","start_time":0,"source_url":"","article_id":"1118495290","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1118495290","pubTimestamp":1773830459,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Guanze Medical Information Industry (Holding) Co., Ltd. (stock code: 02427) has announced that its board of directors will convene on Tuesday, 31 March 2026. The meeting agenda includes: 1. Reviewing...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02427":"GUANZE MEDICAL"},"translate_title":"冠泽医疗(02427)安排2026年3月31日董事会会议批准2025财年业绩及考虑末期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02427":1},"content_text":"Guanze Medical Information Industry (Holding) Co., Ltd. (stock code: 02427) has announced that its board of directors will convene on Tuesday, 31 March 2026.\nThe meeting agenda includes:\n1. Reviewing and, if deemed appropriate, approving the audited annual results for the financial year ended 31 December 2025.\n2. Considering the declaration of a final dividend for FY2025.\n3. Addressing any other business matters.\nChairman Meng Xianzhen issued the notice on 18 March 2026. The board currently comprises Executive Directors Meng Xianzhen and Guo Zhenyu; Non-Executive Director Meng Cathy; and Independent Non-Executive Directors Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.\nThe announcement reiterates that Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited assume no responsibility for the content’s accuracy or completeness.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}